Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, May 27, 2015 3:04:31 PM
bullish
high and tight flag breakout
reference
http://thepatternsite.com/htf.html
## source: finance.yahoo.com
Wed, 27 May 2015 12:03:00 GMT ~ PlasmaTech Biopharmaceuticals to Present at the 2015 Marcum MicroCap Conference
[Marketwired] - PlasmaTech Biopharmaceuticals, Inc. , a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, announces today ...
read full: http://finance.yahoo.com/news/plasmatech-biopharmaceuticals-present-2015-marcum-120300443.html
*********************************************************
Tue, 26 May 2015 17:15:39 GMT ~ REMINDER: PlasmaTech Biopharmaceuticals First Quarter 2015 Conference Call Tomorrow
[Marketwired] - PlasmaTech Biopharmaceuticals, Inc. , a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, will provide ...
read full: http://finance.yahoo.com/news/reminder-plasmatech-biopharmaceuticals-first-quarter-171539579.html
*********************************************************
Fri, 22 May 2015 17:04:22 GMT ~ PLASMATECH BIOPHARMACEUTICALS INC Financials
read full: http://finance.yahoo.com/q/is?s=ptbi
*********************************************************
Wed, 20 May 2015 12:03:00 GMT ~ PlasmaTech Biopharmaceuticals Announces Orphan Drug and Rare Pediatric Disease Designations From FDA
[Marketwired] - PlasmaTech Biopharmaceuticals, Inc. , a biopharmaceutical company focused on gene therapy and plasma-based products for severe and life- threatening rare diseases announced today that the U.S. Food and ...
read full: http://finance.yahoo.com/news/plasmatech-biopharmaceuticals-announces-orphan-drug-120300783.html
*********************************************************
Mon, 18 May 2015 20:32:40 GMT ~ PLASMATECH BIOPHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistere
read full: http://biz.yahoo.com/e/150518/ptbi8-k.html
*********************************************************
$PTBI charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$PTBI company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/PTBI/company-info
Ticker: $PTBI
OTC Market Place: Not Available
CIK code: 0000318306
Company name: PlasmaTech Biopharmaceuticals, Inc.
Company website: http://www.accesspharma.com
Incorporated In: DE, USA
Business Description: Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the development and commercialization of proprietary products for the treatment and supportive care of cancer patients. Access has one approved product, two products in Phase 2 development, and five preclinical development programs. The company's approved product is MuGard(TM) for the management of oral mucositis (a common and debilitating side effect of many cancer therapies) for which marketing authorization has been allowed by the FDA. Access' ProLindac(TM), a polymer-linked platinum cancer drug is in Phase 2 clinical testing in cancer patients, as is Phenylbutyrate, a pleotropic agent which current evidence suggests acts as both an HDAC inhibitor and a differentiating agent. The Company's preclinical development programs include Angiolix, a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is potentially targeted to a number of tumor types, including breast and ovarian; Prodrax, a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill tumor cells; Alchemix, a chemotherapeutic agent that combines two modes of action to overcome drug resistance, and oral insulin, which utilizes the company's Cobalamin(TM) oral drug delivery technology.Less >>
$PTBI share structure
## source: otcmarkets.com
Market Value: $179,699,321 a/o May 26, 2015
Shares Outstanding: 19,988,801 a/o Mar 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$PTBI extra dd links
Company name: PlasmaTech Biopharmaceuticals, Inc.
Company website: http://www.accesspharma.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PTBI+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PTBI+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PTBI+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/news - http://finance.yahoo.com/q/h?s=PTBI+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PTBI/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PTBI+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PTBI
DTCC (dtcc.com): http://search2.dtcc.com/?q=PlasmaTech+Biopharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=PlasmaTech+Biopharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=PlasmaTech+Biopharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.accesspharma.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.accesspharma.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.accesspharma.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PTBI
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000318306&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PTBI&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PTBI
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PTBI+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PTBI+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PTBI
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PTBI
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PTBI+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PTBI/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PTBI+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PTBI.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PTBI
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PTBI
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PTBI
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PTBI:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PTBI
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PTBI
$PTBI DD Notes ~ http://www.ddnotesmaker.com/PTBI
Recent ABEO News
- Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/02/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 11:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 11:09:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 11:08:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 11:07:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 11:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 11:05:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:10:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:10:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:08:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:30:37 AM
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors • GlobeNewswire Inc. • 08/14/2024 11:30:00 AM
- Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel • GlobeNewswire Inc. • 08/13/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 11:35:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:30:12 AM
- Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission • GlobeNewswire Inc. • 08/12/2024 11:30:00 AM
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 08:30:32 PM
- Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications • GlobeNewswire Inc. • 07/11/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:35:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:35:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:35:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:35:38 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM